NCT06888674 2025-03-21Personalized Tumor Neoantigen MRNA Therapy Adjuvant Treatment for Postoperative Pancreatic Cancer.Zhejiang UniversityPhase 1/2 Not yet recruiting60 enrolled
NCT06195670 2024-01-08Clinical Study of Short-course Radiotherapy Followed by Fruquintinib Plus Sintilimab vs Bevacizumab Plus Capecitabine as First Line Treatment in Advanced mCRCZhejiang Cancer HospitalPhase 1/2 Not yet recruiting220 enrolled